Medpace Earnings
NASDAQ: MEDPHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Oct 21, 2026
After market close
Fiscal period
Sep/2026
EPS estimate
$4.45
Medpace earnings summary
Medpace is scheduled to report Sep/2026 earnings on Oct 21, 2026 after the market closes, with analysts expecting EPS of $4.45. In its most recent report on Jul 23, 2026 (Q2 2026), MEDP posted EPS of $4.25. Revenue for the quarter was $707.3 million.
Quarterly EPS is up 37.1% from the same quarter a year earlier. Across the last 16 reports, MEDP shares moved an average of 3.7% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
MEDP earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 23, 2026 | — | $4.25 | — | -4.0% |
| Apr 23, 2026 | — | $4.28 | — | +1.7% |
| Feb 10, 2026 | — | $4.65 | — | +6.0% |
| Oct 23, 2025 | — | $3.86 | — | -3.4% |
| Jul 22, 2025 | — | $3.10 | — | -5.5% |
| Apr 22, 2025 | — | $3.67 | — | +2.2% |
| Feb 11, 2025 | — | $3.67 | — | +0.0% |
| Oct 22, 2024 | — | $3.01 | — | -3.2% |
| Jul 23, 2024 | — | $2.75 | — | -1.2% |
| Apr 23, 2024 | — | $3.20 | — | -0.8% |
| Feb 13, 2024 | — | $2.46 | — | +2.6% |
| Oct 24, 2023 | — | $2.22 | — | +9.6% |
| Jul 25, 2023 | — | $1.93 | — | +1.5% |
| Apr 25, 2023 | — | $2.27 | — | +3.3% |
| Feb 14, 2023 | — | $2.08 | — | -6.6% |
| Oct 25, 2022 | — | $2.05 | — | -6.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.